2014A NASA RallyCross Challenge: Round Nine - Irwindale I
By: ASNtvUSA
Continued here:
2014A NASA RallyCross Challenge: Round Nine - Irwindale I - Video
2014A NASA RallyCross Challenge: Round Nine - Irwindale I
By: ASNtvUSA
Continued here:
2014A NASA RallyCross Challenge: Round Nine - Irwindale I - Video
2014A NASA RallyCross Challenge: Round 10 - Irwindale II
By: ASNtvUSA
Here is the original post:
2014A NASA RallyCross Challenge: Round 10 - Irwindale II - Video
NASA - UFO ACTIVITY ON THE MOON
NASA - UFO ACTIVITY ON THE MOON NASA - ATIVIDADE UFO NA LUA Cooper ex-agente da CIA falava que durante o comeo da explorao espacial norte-americana, com suas poucas descidas na Lua,...
By: Kovastein Mihaelovic
More here:
September 29, 2014
Image Caption: SNC's Dream Chaser on runway at NASA's Dryden Flight Research Center at dawn. Credit: Sierra Nevada Corporation/NASA
Chuck Bednar for redOrbit.com Your Universe Online
Sierra Nevada Corp (SNC) has filed a formal protest over NASAs decision to grant a total of $6.8 billion in contracts to Boeing and SpaceX for the construction of next-generation vehicles to transport American astronauts to and from the International Space Station (ISS).
Those agreements, which were announced earlier this month, could pay Boeing up to $4.2 billion for use of their commercially owned and operated CST-100, and another $2.6 billion to SpaceX for use of their Dragon spacecraft. The goal is to have domestically-made vehicles available for use in manned missions by 2017.
SNC, which was also under consideration for those contracts, said that their bid could have saved NASA up to $900 million and that statements made by officials at the US space agency indicate that there are serious questions and inconsistencies in the source selection process, said Reuters reporters Andrea Shalal and Mohammad Zargham.
With the current awards, the U.S. government would spend up to $900 million more at the publicly announced contracted level for a space program equivalent to the program that SNC proposed, Sierra Nevada said in a statement. SNC, therefore, feels that there is no alternative but to institute a legal challenge, it continued, noting that a thorough review of NASAs decision to award the contracts must be conducted.
Furthermore, Andy Pasztor of the Wall Street Journal pointed out that SNC said the US space agencys selection of Boeing and CST-100 would result in a substantial increased cost to the public despite near equivalent technical and past performance scores, and that NASAs own selection records and debrief indicate the presence of serious questions and inconsistencies in the source selection process.
A NASA spokeswoman told Pasztor that the agency would have no comment while the legal challenge is pending with the US Government Accountability Office (GAO), which must determine whether or not the complaint is valid. That process can take several months, the Wall Street Journal reporter added. NASA has not publically released the selection criteria, or how each of the three firms ranked in terms of technical, management and cost issues.
While Pasztor said that SNC was the only bidder to propose a winged vehicle able to land on a runway during its return trip from the international space station, he added that sources had informed him the company lagged behind the other two bidders in some technical rankings. Sierra Nevada said in their statement that its proposal was the second lowest priced and that it had achieved mission suitability scores comparable to its rivals.
Here is the original post:
Sierra Nevada Challenges NASA Decision On Crew Transport Contracts
Image Caption: Artists concept of an atom chip for use by NASAs Cold Atom Laboratory (CAL) aboard the International Space Station. CAL will use lasers to cool atoms to ultracold temperatures. Credit: NASA
Elizabeth Landau, NASA
Like dancers in a chorus line, atoms movements become synchronized when lowered to extremely cold temperatures. To study this bizarre phenomenon, called a Bose-Einstein condensate, researchers need to cool atoms to a temperature just above absolute zero the point at which atoms have the least energy and are close to motionless.
The goal of NASAs Cold Atom Laboratory (CAL) is to study ultra-cold quantum gases in a facility instrument developed for use on the International Space Station. Scientists will use the facility to explore how differently atoms interact in microgravity when they have almost no motion due to such cold temperatures. With less pull toward the ground from Earth, matter can stay in the form of a Bose Einstein condensate longer, giving researchers the opportunity to observe it better.
The CAL team announced this week that it has succeeded in producing a Bose-Einstein condensate at NASAs Jet Propulsion Laboratory, a key breakthrough for the instrument leading up to its debut on the space station in late 2016.
A Bose-Einstein condensate is a collection of atoms in a dilute gas that have been lowered to extremely cold temperatures and all occupy the same quantum state, in which all of the atoms have the same energy levels. At a critical temperature, atoms begin to coalesce, overlap and move in synch. The resulting condensate is a new state of matter that behaves like a giant by atomic standards wave.
Its official. CALs ground testbed is the coolest spot at NASAs Jet Propulsion Laboratory at 200 nano-Kelvin [200 billionths of 1 Kelvin], said CAL Project Scientist Rob Thompson at JPL in Pasadena, California. Achieving Bose-Einstein condensation in our prototype hardware is a crucial step for the mission.
Although these quantum gases had been created before elsewhere on Earth, CAL will explore the condensates in an entirely new regime: the microgravity environment of the space station. It will enable unprecedented research in temperatures colder than any found on Earth.
In the stations microgravity environment, long interaction times and temperatures as low as one picokelvin (one trillionth of one Kelvin, or 293 trillion times less than room temperature) should be achievable. Thats colder than anything known in nature, and the experiments with CAL could potentially create the coldest matter ever observed in the universe. These breakthrough temperatures unlock the potential to observe new quantum phenomena and test some of the most fundamental laws of physics. The CAL investigation could advance our knowledge in the development of exquisitely sensitive quantum detectors, which could be used for monitoring the gravity of the Earth and other planetary bodies, or for building advanced navigation devices.
Ultra-cold atoms will also be useful for space-based optical clocks that will be future time standards, Thompson said.
More:
It seems too round to be true the Curiosity rover has found a ball-shaped object among the craggy rocks in its picture. This image was taken on Sol 746 of the rovers mission on Mars, which so far has extended over two Earth years.
No, its not the leftover of a Martian baseball game and nor is it aliens. In fact, according toDiscovery News(who is quoting NASA) its a kind of rock that shows evidence of water in the ancient past.
Ian ONeill writes:
According to MSL scientists based at NASAs Jet Propulsion Laboratory (JPL) in Pasadena, Calif., the ball isnt as big as it looks its approximately one centimeter wide. Their explanation is that it is most likely something known as a concretion. Other examples of concretions have been found on the Martian surface before take, for example, the tiny haematite concretions, or blueberries, observed by Mars rover Opportunity in 2004 and they were created during sedimentary rock formation when Mars was abundant in liquid water many millions of years ago.
Curiosity isnow at the base of Mount Sharp (Aeolis Mons) its main science goal and scientists are hoping to find more signs of habitable environments as the rover slowly prepares for the climb up the slope. Mission managers will need to be careful as therover has battered wheelsfrom rougher terrain than expected.
The rover already has found other evidence of water in its landing site of Gale Crater, such as thisancient lakebed that could have supported life.
Elizabeth Howellis the senior writer at Universe Today. She also works for Space.com, Space Exploration Network, the NASA Lunar Science Institute, NASA Astrobiology Magazine and LiveScience, among others. Career highlights include watching three shuttle launches, and going on a two-week simulated Mars expedition in rural Utah. You can follow her on Twitter@howellspaceor contact her ather website. FollowElizabeth Howell on Google+.
Originally posted on Universe Today.
Read the original post:
Washington | Updated 9/29/2014 11:50:57 AM IST
Washington: NASA's Curiosity rover has just drilled its first hole in the foothills of Mount Sharp, the 5-kilometre-high mountain on Mars that is the primary destination for the six-wheeled machine's mission. The rover's hammering drill chewed about 2.6 inches deep into a basal-layer outcrop on Mount Sharp last week and collected a powdered-rock sample. The powder collected by the drilling is temporarily held within the sample-handling mechanism on the rover's arm. "This drilling target is at the lowest part of the base layer of the mountain, and from here we plan to examine the higher, younger layers exposed in the nearby hills," said Curiosity Deputy Project Scientist Ashwin Vasavada of NASA's Jet Propulsion Laboratory (JPL). "This first look at rocks we believe to underlie Mount Sharp is exciting because it will begin to form a picture of the environment at the time the mountain formed, and what led to its growth," said Vasavada. After landing on Mars in August 2012 but before beginning the drive towards Mount Sharp, Curiosity spent much of the mission's first year productively studying an area much closer to the landing site, but in the opposite direction. The mission accomplished its science goals in that Yellowknife Bay area. Analysis of drilled rocks there disclosed an ancient lake-bed environment that, more than three billion years ago, offered ingredients and a chemical energy gradient favourable for microbes, if any existed there. From Yellowknife Bay to the base of Mount Sharp, Curiosity drove more than 8 kilometres in about 15 months, with pauses at a few science waypoints. The emphasis in mission operations has now changed from drive, drive, drive to systematic layer-by-layer investigation, NASA said. "We're putting on the brakes to study this amazing mountain. Curiosity flew hundreds of millions of miles to do this," said Curiosity Deputy Project Manager Jennifer Trosper of JPL. Curiosity on September 19 arrived at an outcrop called "Pahrump Hills," which is a section of the mountain's basal geological unit, called the Murray formation. Three days later, the rover completed a "mini-drill" procedure at the selected drilling target, "Confidence Hills," to assess the target rock's suitability for drilling. A mini-drill activity last month determined that a rock slab under consideration then was not stable enough for full drilling, but Confidence Hills passed this test. The rock is softer than any of the previous three targets where Curiosity has collected a drilled sample for analysis. PTI
See the original post here:
One of the winning images of the 2014 Nano Today Cover Competition. Look out for more cover competition winners, here on Materials Today.
The new issue of Nano Today (Volume 9, Issue 4) is out now. Click here to read the articles.
Titanium dioxide (TiO2) is one of the most important oxides; it has been widely investigated due to its high dielectric constant, humidity and oxygen sensitivities and photoelectric and catalytic conversion properties [13], excellent electronic, magnetic, optical, and mechanical properties [47] and hence it has numerous applications in photovoltaic cells or dye and quantum dot sensitized solar cells (DSSC, QDSSC), photocatalysis, Li-ion battery materials, sensors, etc: mainly due to its wide-band-gap semiconductor properties [811].
DSSC, using nanocrystalline TiO2 as photoanode material, has captured more and more attention because of the low cost of the material and its fabrication, and it is regarded as one of the most promising alternatives to the commercial silicon based solar cells presently available. The photoanode material has been found to play an important role in the photovoltaic performance of a DSSC since it influences the dye loading, light scattering and electron transport. Remarkable achievements have been made by using TiO2 photoelectrode with various morphologies such as nanoparticles, sub-micro-spheres, beads, one-dimensional (1D) or quasi-1D nanoarrays such as nanorods/wires and nanotubes. These 1Dstructures can be recognized as effective pathways for the facilitation of electron transport and minimization of the recombination rate, resulting in an improvement of the charge collection efficiency.
Present work demonstrates the synthesis of titanium dioxide cauliflower-like nanostructures possessing high surface area and hierarchical nonstructural formation leading to effective light harvesting which can be further exploited as a photoanodes for the DSSC. Herein, we report on the chemical synthesis of TiO2 broccoli using a facile and low cost hydrothermal method without any catalysts or templates for preparing rutile TiO2 crystals merely by adjusting the amount of titanium tetrachloride precursor amounts.
The photoelectrochemical activities are found to be dependent on the morphology of the photoanodes; therefore morphology control of TiO2 is supposed to be an effective way to improve the photoelectrochemical performance. Hierarchical architectures have attracted more and more researchers in recent years, compared to nanoparticles, due their high surface-to-volume ratio, high organic pollutant adsorption, and excellent incident light scattering within the structures. Nowadays, efforts are focused on the investigation of hierarchical architectures instead of conventional nanoparticles for further enhancement of the photoelectrochemical performance of TiO2.
The material shown on this cover of Nano Today was synthesized at Thin Film Materials Laboratory, Department of Physics, Shivaji University, Kolhapur, Maharashtra, INDIA. It resulted from a Ph. D. work of Mr. Sachin A. Pawar under the supervision of Prof. Pramod S. Patil. The TiO2 produced has used as photoanode for Quantum dot sensitized solar cells application.
Acknowledgments
The financial support from UGC-SAP-DSA-I, New Delhi and Department of Science and Technology (DST) INDIA through DST FIST-II and DST-PURSE scheme is acknowledged. This work is partially supported by the Human Resource Development of the Korea Institute of Energy technology Evaluation and Planning (KETEP) grant funded by the Korea Government Ministry of knowledge Economy (No. 20124010203180). Dr. Rupesh S. Devan and Prof. Yuan R. Ma from National Dong Hwa University, Taiwan are acknowledged for assistance with FE-SEM/EDS/XPS analyses.
Corresponding Authors Emails: patilps_2000@yahoo.com (Prof. Pramod S. Patil), sachinpawar69@gmail.com (Mr. Sachin A. Pawar).
Read more:
BETHESDA, MD (PRWEB) September 29, 2014
The very first sensitive and specific molecular imaging technique to detect bone metastases was recently developed by NFCR-funded scientist Paul B. Fisher, M.Ph., Ph.D., at the Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine in collaboration with Martin G. Pomper, M.D., Ph.D., at the Johns Hopkins Medical Institutions.
This new genetic-based imaging technique is able to detect cancerous cells through expression of a gene called AEG-1, which was originally discovered by Dr. Fisher. AEG-1 is expressed at high levels in all cancer types investigated so far, with limited expression in normal tissue.
Importantly, laboratory work with metastatic tumor models demonstrated that this technique was even able to detect prostate cancer lesions that have metastasized (spread) to the bone. Bone metastasis is the number one cause of death for patients with prostate cancer.
Bone metastases are notoriously difficult to detect with molecular imaging, said Dr. Fisher. There is currently no sensitive and specific imaging technique clinically available to detect cancer in the bones. The results indicate that this new technique represents a great improvement over current clinical imaging techniques.
We expect this to have applications well beyond bone metastasis in prostate cancer, said Dr. Fisher. Because AEG-1 is expressed in the majority of cancers, this research could potentially lead to earlier detection and treatment of metastases originating from a variety of cancer types.
The imaging system may even have applications beyond diagnostic imaging; it has been suggested that it could be combined with therapeutic agents, allowing physicians to image drug delivery in real time. Dr. Fisher and colleagues are working to overcome the remaining obstacles and move this technology into the clinic as soon as possible.
Dr. Fishers work represents a true breakthrough in the fight against cancer, said Franklin Salisbury, Jr., president of the National Foundation for Cancer Research At NFCR we firmly believe that basic research can and should be translated from the bench to the bedside. This is what we mean by Research for a Cure.
This work was funded in part by the National Foundation for Cancer Research. The results were published in the September 18, 2014 Online First edition of the journal Cancer Research.
About the National Foundation for Cancer Research
Follow this link:
Indie Fridays #24 - Ends October 3, 2014
Available to Arcade Pixels Network and all Freedom! partners. Apply to this Indie Friday here - https://docs.google.com/forms/d/13Wslg2Jq3AEbmz_hfjbrdOeZ8LEp...
By: ArcadePixels IndiePromo
Visit link:
'Now I'm the 'JetBlue selfie guy': Scott Welch's selfie went viral on YouTube. Photo: YouTube
JetBlue Flight 1416 was just minutes into its trip from Long Beach, California, to Austin, Texas, on September 18 when Scott Welch, a passenger in Seat 5A, heard a suspicious pop. Moments later, smoke began to fill the cabin, clogging the air to the point that he could see only a few rows in front of him, he said. The starboard engine of the Airbus A320, he soon learned, had blown.
As other passengers began to cry and pray, Welch strapped on his oxygen mask and pondered his fate.
"I understood that I might be going to meet God," Welch, 34, recalled. He thought, "If this is my time, this is my time."
When his plane cabin filled with smoke, Scott Welch quickly pulled out his phone. Photo: YouTube
Faced with his own mortality, he could have closed his eyes in quiet reflection. Instead, Welch, a sports photographer, responded in a distinctly 2014 manner: He reached for his Samsung Galaxy Note 3 smartphone, thrust it into the murky air and pressed the "record" button. He even found the presence of mind to record a smiling selfie.
Advertisement
Never mind that the plane landed safely soon after, making the mechanical failure a relative nonevent. The pulse-quickening, you-are-there footage captured by Welch and other passengers helped propel the story to national news. Welch's two brief videos, meanwhile, went viral; one attracted more than 1 million views.
It is no longer enough to record seemingly every last moment of life with your smartphone, it seems. Near-death is fair game, too.
Thanks to the Personal Video Industrial Complex - tens of millions of video-enabled smartphones, feeding countless hours daily to video-sharing behemoths - rock concerts, presidential inaugurations, fourth-grade school plays and even midair near-disasters can all be considered "content" now, inspiring us all to tap our inner Edward R. Murrow and record the event for posterity.
Excerpt from:
DHL parcelcopter drone to deliver medicine to remote German island
German logistics firm DHL has been given permission to use a drone to deliver parcels to Juist island, the first time that an unmanned aircraft has been auth...
By: TomoNews US
Visit link:
DHL parcelcopter drone to deliver medicine to remote German island - Video
FIU Athletic Medicine Facility Tour
By: FloridaInternational
Link:
Alan Lee, MD | Santa Monica 15th Street Family Medicine - UCLA Health
Learn more about Alan Lee, MD at http://www.uclahealth.org/AlanLee Learn more about Santa Monica 15th Street Family Medcine at http://www.uclahealth.org/SM15thStreet.
By: UCLA Health
Continued here:
Alan Lee, MD | Santa Monica 15th Street Family Medicine - UCLA Health - Video
Ann Ryan, MD | Santa Monica 15th Street Family Medicine - UCLA Health
Learn more about Ann Ryan, MD at http://www.uclahealth.org/AnnRyan Learn more about Santa Monica 15th Street Family Medcine at http://www.uclahealth.org/SM15thStreet.
By: UCLA Health
Read more:
Ann Ryan, MD | Santa Monica 15th Street Family Medicine - UCLA Health - Video
Personalized Medicine The Glucocorticoid Receptor, David Greenhalgh, M.D.
Department of Surgery Grand Rounds 080514 Speaker: David Greenhalgh, M.D. Burn Surgery.
By: UC Davis Department of Surgery
Go here to see the original:
Personalized Medicine The Glucocorticoid Receptor, David Greenhalgh, M.D. - Video
About the Turning the Tide Against Cancer Co-Conveners: Personalized Medicine Coalition
The Personalized Medicine Coalition (PMC) is an education and advocacy organization that is focused on encouraging innovation in personalized medicine. Learn more about their role as a ...
By: TTTACancer
Follow this link:
About the Turning the Tide Against Cancer Co-Conveners: Personalized Medicine Coalition - Video
Medicine and Eye Care!
Everything that you see I brought!
By: Eye Love Two Save
Read this article:
Men who take a daily dose of aspirin or similar anti-inflammatory medicine may also reduce their risk of developing prostate cancer, researchers said.
The study, presented today at an American Association for Cancer Research meeting, found that men who regularly used anti-inflammatory pain pills had a 13 percent lower risk of prostate cancer and 17 percent fewer dangerous, high-grade tumors. A second study suggested the mechanism responsible for preventing the tumors could be the medicines ability to block production of a hormone that spurs cancer growth.
Low-dose aspirin is taken by millions of Americans to prevent heart attacks and strokes, said Pierre Massion, a professor of medicine and cancer biology at Vanderbilt University School of Medicine in Nashville who worked on the research. It has been shown to prevent colon cancer. What we are saying is that the benefit of aspirin even at low doses could also help other cancers, including lung, breast and prostate.
While promising results have been shown in studies of other tumor types, people generally dont take aspirin to prevent cancer or slow its growth. One obstacle was that researchers didnt know how aspirin worked on tumors. The new findings help answer those questions, Massion said in a telephone interview.
We found the mechanism to explain how low-dose aspirin can eventually decrease the incidence of new cancers after you have taken it for five years or more, he said. It can also explain why people who are taking aspirin after being diagnosed have a lower risk of dying of their metastases.
Massions laboratory study showed aspirin inhibited production of Cox-2, which then reduced levels of a prostaglandin called PGE2 that spurs cancer metastases. The findings mean aspirin doesnt only prevent blood platelets from sticking together, the primary way it helps reduce heart attacks. At the cellular level, it can also block Cox-2 in cancer, he said.
Studies to prevent prostate and other cancers with Merck & Co.s Vioxx, a pain medicine that blocked Cox-2, were halted after the drug was pulled from the market because of its heart disease risks. Pfizer Inc. hasnt developed its Cox-2 inhibitor Celebrex for prostate cancer, though it is approved to treat a rare condition where intestinal polyps can lead to colon cancer.
Adriana Vidal, an assistant professor at Duke University School of Medicine and the lead author of the study that looked at prostate cancer rates, said more research is needed. The drugs have side effects, including gastrointestinal bleeding, which have to be weighed against the benefits, she said. The study was based on the patients self-reported use of aspirin and pain medicine.
To contact the reporter on this story: Michelle Fay Cortez in Minneapolis at mcortez@bloomberg.net
To contact the editors responsible for this story: Reg Gale at rgale5@bloomberg.net Drew Armstrong, Andrew Pollack
Original post:
Increased budgets and higher financial returns in the battle to stave off the ageing process mean that Regenerative Medicine is becoming the new darling of the US transhumanist movement.
The US population is ageing. In 2030, 20% of all US Americans will be over 65 years old. Billionaire Peter Thiel, the founder of Paypal and a key Silicon Valley player, strongly believes in the need to support work on regenerative biology and has donated millions of dollars to the SENS (Strategies for Engineered Negligible Senescence) Foundation established by the controversial English biologist Aubrey de Grey. Meanwhile the anti-ageing biotechnology market has been seeing huge growth, both in terms of rising turnover currently amounting to some $2 billion according to investment and advisory firm Proteus Venture Partners and the enthusiasm it has aroused among many scientists, manufacturers and politicians. However, reactions in the scientific community have been mixed, with some experts expressing scepticism about anti-ageing efforts. Given our current ignorance of the subject, the promises made for this new approach to medicine are at best speculation.
In 2013 Google dipped its toe into the waters of the anti-ageing therapy business when it founded the California Life Company (Calico), an independent biotech R&D firm whose stated aim is to extend the natural lifespan of human beings. However, research in this field has been somewhat hampered by popular association with upstart companies offering rather fanciful cryopreservation services (i.e. storing the bodies of recently deceased people at very low temperatures in the hope of future cure and resuscitation) to people about to die. Thus the image of the relatively new field of Regenerative Medicine has been tarnished among the scientific community by the rise of a brash anti-death industry. It was probably largely to counter this negative image that radiologist and investor Joon Yun recently inaugurated the Palo Alto Longevity Prize, a $1 million life science competition dedicated to ending ageing in humans. Joon Yun explains that the purpose of the competition is to provide a way to urge researchers to hack the ageing code, taking up the torch from James Watson and Francis Crick, the UK-based scientists who first revealed the three-dimensional double helix structure of the DNA molecule. In fact, back in 2011, when the anti-ageing ecosystem was far less advanced than it is today, the United States Congress got into step with the new thinking when it passed the The Regenerative Medicine Promotion Act, designed to provide funding for this new avenue of research and foster its development. However, the scientific community has not been unanimously behind this drive and much controversy is raging over current anti-ageing initiatives. Criticism usually centres on the over-optimistic tone of many researchers backed by the SENS Foundation, which some experts say is not justified by actual progress to date.
Much current research into the ageing process takes a rather utilitarian approach to mortality defining ageing as the gradual deterioration of an organism and arguing that it should be perfectly possible to make repairs fast enough to keep ahead of the ongoing decline. The general hypothesis is that if death is the result of organism deterioration then it follows that repairing the deteriorating cells should delay death. However, the anti-ageing battle is being fought on two separate fronts, in terms of the basic objectives and means applied. On the one hand there are the well-established biotech processes, including 3D bio-printers, ranging from the CRISPR gene editing system to the Regenovo cell-printer, which already enable living organisms, from sequenced genomes to complete organs, to be manufactured. The journal Rejuvenation Research first appeared as long ago as 1998, spearheaded by Editor-in-Chief Aubrey de Grey, whose career has ranged from computer programming to applied biology. Aubrey de Grey also co-founded The Methuselah Foundation in 2003, before setting up SENS in 2009. Their credo is that bio-medicine must be rooted in the living organisms metabolism in order to treat the pathological condition, the aim being to act specifically to repair the damage done to the organism by using rejuvenating engineering techniques. Aubrey de Grey and his colleagues argue that the answer to ageing is Regenerative Medicine at the cellular level, providing appropriate treatment for the cells whether they are mutating to become cancerous or simply ageing.
See more here:
Combating Ageing: from Biotech Printing to Regenerative Medicine